Cargando…
CB(1)R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
The soluble isoform of leptin receptor (sOb-R), secreted by the liver, regulates leptin bioavailability and bioactivity. Its reduced levels in diet-induced obesity (DIO) contribute to hyperleptinemia and leptin resistance, effects that are regulated by the endocannabinoid (eCB)/CB(1)R system. Here w...
Autores principales: | Drori, Adi, Gammal, Asaad, Azar, Shahar, Hinden, Liad, Hadar, Rivka, Wesley, Daniel, Nemirovski, Alina, Szanda, Gergő, Salton, Maayan, Tirosh, Boaz, Tam, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728447/ https://www.ncbi.nlm.nih.gov/pubmed/33210603 http://dx.doi.org/10.7554/eLife.60771 |
Ejemplares similares
-
Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling
por: Tam, Joseph, et al.
Publicado: (2017) -
Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
por: Hinden, Liad, et al.
Publicado: (2022) -
Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity‐induced chronic kidney disease
por: Udi, Shiran, et al.
Publicado: (2019) -
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB(1)R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
por: Hirsch, Shira, et al.
Publicado: (2023) -
A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities
por: Permyakova, Anna, et al.
Publicado: (2020)